Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,049.95
-5.9724-0.29%
Number of Gainers:472
Number of Losers:529
Number of Flat:23
PE:- -
High:2,056.94
Open:2,055.94
Low:2,041.62
Close:2,055.92
Volume:5.42B
Turnover:704.66B
Market Cap:95.54T
Float Cap:89.34T

Loading ...

T. Rowe Price reports preliminary AUM $1.9T as of August 31

TIPRANKS
·
Sep 11

Deutsche sees Estee shares topping $120 by year-end in ‘bull case’

TIPRANKS
·
Sep 11

Political and General News Events from September 11

Reuters
·
Sep 11

August CPI Report Shows Core Inflation was Hotter than Expected - Live Updates

Dow Jones
·
Sep 11

BofA Securities Upgrades International Paper to Buy From Neutral, Adjusts Price Target to $46 From $48

MT Newswires Live
·
Sep 11

BofA Adjusts Price Target on Humana to $510 From $500

MT Newswires Live
·
Sep 11

BofA Securities Adjusts Centene Price Target to $80 From $78

MT Newswires Live
·
Sep 11

Oil Prices Set to Shift Tonight as Authorities Roll Out Temporary Measures

Deep News
·
Sep 11

Domestic Fuel Prices Set to Rise Tonight Amid Government Intervention

Deep News
·
Sep 11

T. Rowe Price Reports August AUM of $1.9 Trillion

Reuters
·
Sep 11

Palantir, Voyager-Backed Starlab Seeks ISS Microgravity Research Proposals

MT Newswires Live
·
Sep 11

Draganfly Wins Five-Year Canada Contract for 100 Tactical Drone Systems

Reuters
·
Sep 11

Quantum BioPharma Wins FDA Clearance for Lucid-MS Phase 2 Trial

Reuters
·
Sep 11

BofA Securities Adjusts PT on Packaging Corp. of America to $260 From $280, Maintains Buy Rating

MT Newswires Live
·
Sep 11

Fuel Tech Wins Air Pollution Control Contracts Worth $2.8 Million

Reuters
·
Sep 11

Vulcan Infrastructure and Power Names Bob Foley, Allan Rothschild, Jacky Wu to Board

Reuters
·
Sep 11

Analysts Offer Insights on Healthcare Companies: Medicus Pharma Ltd (MDCX) and Labcorp Holdings (LH)

TIPRANKS
·
Sep 11

T. Rowe Price Group, - T. Rowe Price Group Reports Aum of $1.90 Trln as of August 31, 2026

THOMSON REUTERS
·
Sep 11

Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials

GlobeNewswire
·
Sep 11

Celestica Announces New Leadership Structure to Support Unprecedented Growth

GlobeNewswire
·
Sep 11